OXFORD, UK: Oxford Biomedica plc (LSE:OXB), a leading gene and cell therapy group, today announced that its subsidiary Oxford Biomedica Solutions LLC (“Oxford Biomedica Solutions”), a high-performing full-scope scope AAV manufacturing and innovation business, has signed an agreement with a new undisclosed, U.S. based, private biotechnology company. The agreement grants the partner access to Oxford…